VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1643692
Sex: F
Age: 72
State: TX

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Mammogram; Result Unstructured Data: Clear; Test Name: Ultrasound; Result Unstructured Data: Clear

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: swollen lymph nodes under her right arm; tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes under her right arm) and TENDERNESS (tender to touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes under her right arm) and TENDERNESS (tender to touch). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes under her right arm) and TENDERNESS (tender to touch) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: (normal) Clear. On an unknown date, Ultrasound scan: (normal) Clear. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications included medications for Blood Pressure and Hormonal replacement. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness: Blood pressure

ID: 1643693
Sex: F
Age: 73
State: VT

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Flu-like symptoms; chills; sore arm - "it was bad"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (flulike symptoms), CHILLS (chills) and MYALGIA (sore arm - "it was bad") in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Medical history was not provided by the reporter. Concomitant products included CARIPRAZINE HYDROCHLORIDE (VRAYLAR) for Antidepressant therapy, VILAZODONE HYDROCHLORIDE (VIIBRYD) and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flulike symptoms), CHILLS (chills) and MYALGIA (sore arm - "it was bad"). At the time of the report, INFLUENZA LIKE ILLNESS (flulike symptoms), CHILLS (chills) and MYALGIA (sore arm - "it was bad") had not resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. The patient reported that she was still experiencing the same side effects about 138 days later after her first and second dose. She saw her physician but they didn't know what to do for her. Treatment was reported as none taken. This case was linked to MOD-2021-238895 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Event outcomes were updated.

Other Meds: VRAYLAR; VIIBRYD; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1643694
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Other adverse events after receiving the moderna cov-19; Had some joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Other adverse events after receiving the moderna cov-19) and ARTHRALGIA (Had some joint pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Other adverse events after receiving the moderna cov-19) and ARTHRALGIA (Had some joint pain). At the time of the report, VACCINATION COMPLICATION (Other adverse events after receiving the moderna cov-19) and ARTHRALGIA (Had some joint pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643695
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: antibiotic taken at time of ssecond shot; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (antibiotic taken at time of ssecond shot) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (antibiotic taken at time of ssecond shot). At the time of the report, ADVERSE EVENT (antibiotic taken at time of ssecond shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were provided.

Other Meds:

Current Illness:

ID: 1643696
Sex: F
Age: 73
State: VT

Vax Date: 02/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sore arm and that the shot on the right side was worse; flu-like symptoms; Chills ever since the shot/not like goosebumps chills like internal chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm and that the shot on the right side was worse), CHILLS (Chills ever since the shot/not like goosebumps chills like internal chills) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006821A and 030M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included CARIPRAZINE HYDROCHLORIDE (VRAYLAR) for Depression, VILAZODONE HYDROCHLORIDE (VIIBRYD) and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced CHILLS (Chills ever since the shot/not like goosebumps chills like internal chills). On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm and that the shot on the right side was worse) and INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, VACCINATION SITE PAIN (Sore arm and that the shot on the right side was worse), CHILLS (Chills ever since the shot/not like goosebumps chills like internal chills) and INFLUENZA LIKE ILLNESS (flu-like symptoms) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information was not provided. This case was linked to MOD-2021-238880 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up information received on 21 Jul 2021,contains event information-no new information - Patient reported that she was still experiencing the same side effects 138 days later after her 2nd dose. On 21-Jul-2021: Follow-up information received on 21 Jul 2021,contains no new information - Patient saw her Doctor. On 21-Jul-2021: Follow-up information received on 21 Jul 2021,contains physician details added. On 27-Jul-2021: Follow Up Information received on 27 Jul 2021, chills not recovered, met doctor twice

Other Meds: VRAYLAR; VIIBRYD; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1643697
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: I had the shot a couple of days ago and did go down like a brick that night and the next day; the injection site is still really red on my arm; very sore; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day), VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day), VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore). At the time of the report, FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day) was resolving and VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643698
Sex: F
Age: 65
State: NJ

Vax Date: 03/10/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: experienced dry pain on my knees; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (experienced dry pain on my knees) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and APIXABAN (ELIQUIS) for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced ARTHRALGIA (experienced dry pain on my knees). At the time of the report, ARTHRALGIA (experienced dry pain on my knees) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was unknown. This case was linked to MOD-2021-238940.

Other Meds: BABY ASPIRIN; ELIQUIS

Current Illness:

ID: 1643699
Sex: F
Age: 75
State: AR

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: she started with swelling in hands; SWELLING FACE; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (she started with swelling in hands) and SWELLING FACE (SWELLING FACE) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ALLOPURINOL and PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PERIPHERAL SWELLING (she started with swelling in hands) and SWELLING FACE (SWELLING FACE). The patient was treated with CHLORPHENAMINE MALEATE (CHLOR-TRIMETON) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (she started with swelling in hands) and SWELLING FACE (SWELLING FACE) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-238930 (Patient Link).

Other Meds: ALLOPURINOL; INDERAL

Current Illness:

ID: 1643700
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Is feeling nausea a normal side effect; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Is feeling nausea a normal side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Is feeling nausea a normal side effect). At the time of the report, NAUSEA (Is feeling nausea a normal side effect) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided by reporter. Treatment medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1643701
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: I contracted COVID-19 about 10 days after receiving my first Moderna vaccine.; One of my symptoms was canker sores in my mouth; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I contracted COVID-19 about 10 days after receiving my first Moderna vaccine.) and APHTHOUS ULCER (One of my symptoms was canker sores in my mouth) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I contracted COVID-19 about 10 days after receiving my first Moderna vaccine.) and APHTHOUS ULCER (One of my symptoms was canker sores in my mouth). At the time of the report, COVID-19 (I contracted COVID-19 about 10 days after receiving my first Moderna vaccine.) and APHTHOUS ULCER (One of my symptoms was canker sores in my mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medication was reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643702
Sex: F
Age: 75
State: AR

Vax Date: 02/26/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Next day after receiving 2nd dose, she started with noise in her head,still bothering her; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Next day after receiving 2nd dose, she started with noise in her head,still bothering her) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ALLOPURINOL and PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced TINNITUS (Next day after receiving 2nd dose, she started with noise in her head,still bothering her). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2021-238917 (Patient Link).

Other Meds: ALLOPURINOL; INDERAL

Current Illness:

ID: 1643703
Sex: F
Age: 65
State: NJ

Vax Date: 03/10/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Name: D-Dimer level; Result Unstructured Data: too high

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Pain on the bottom of my feet/Pain on fingers; Pain on knee; Migraine headache; Chills; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and APIXABAN (ELIQUIS) for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MIGRAINE (migraine headache), CHILLS (chills), PYREXIA (Fever) and NAUSEA (Nausea). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and ARTHRALGIA (Pain on knee). On an unknown date, the patient experienced GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.). At the time of the report, MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers), INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.), CHILLS (chills), PYREXIA (Fever), NAUSEA (Nausea) and ARTHRALGIA (Pain on knee) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Fibrin D dimer: high (High) too high. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient went to doctor and was told to take Eliquis. Action taken with mRNA-1273 in response to the event was not applicable . This case was linked to MOD-2021-238916 (Patient Link).

Other Meds: BABY ASPIRIN; ELIQUIS

Current Illness:

ID: 1643704
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: subcutaneous injection; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (subcutaneous injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1643705
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Swelling; Severe Hip pain; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain). At the time of the report, SWELLING (Swelling) and ARTHRALGIA (Severe Hip pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1643706
Sex: F
Age: 84
State: DE

Vax Date: 02/05/2021
Onset Date: 06/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210626; Test Name: Body temperature; Result Unstructured Data: 99.0 Degrees

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Heavy head; Had chills; Had body aches; Had fever of 99 degrees under the arm; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Heavy head), CHILLS (Had chills), MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C10A21A and 03L20A) for COVID-19 vaccination. No medical history were reported. . On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jun-2021, the patient experienced CHILLS (Had chills). 26-Jun-2021, the patient experienced MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm). On 28-Jun-2021, the patient experienced HEAD DISCOMFORT (Heavy head). On 28-Jun-2021, HEAD DISCOMFORT (Heavy head), CHILLS (Had chills), MYALGIA (Had body aches) and PYREXIA (Had fever of 99 degrees under the arm) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jun-2021, Body temperature: 99.0 (normal) 99.0 Degrees. No concomitant medications were reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643707
Sex: U
Age:
State:

Vax Date: 05/03/2021
Onset Date: 05/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May). On 31-May-2021, PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product information was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643708
Sex: U
Age:
State:

Vax Date: 06/27/2021
Onset Date: 06/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Right side about 4" below belly button a dull ache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, the patient experienced ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache). At the time of the report, ABDOMINAL PAIN LOWER (Right side about 4" below belly button a dull ache) outcome was unknown. No concomitant medications were reported. Treatment information was unknown.

Other Meds:

Current Illness:

ID: 1643709
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Adverse event; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse event). At the time of the report, ADVERSE EVENT (Adverse event) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Treatment information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1643710
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: fast heartbeat; Result Unstructured Data: increase

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: started to sweat a lot; felt week; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week). At the time of the report, HYPERHIDROSIS (started to sweat a lot) and ASTHENIA (felt week) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: high (High) increase. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. no concomitant medications are provided. treatment to the events not reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643711
Sex: F
Age: 56
State:

Vax Date: 05/18/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: anxiety attacks; feeling nervous; nausea without vomiting; This spontaneous case was reported by a non-health professional and describes the occurrence of ANXIETY (anxiety attacks), NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxiety attacks), NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting). The patient was treated with LORAZEPAM for Anxiety, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (feeling nervous) and NAUSEA (nausea without vomiting) outcome was unknown. No concomitant medication was reported. This case was linked to MOD-2021-100492 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up received: Outcome of anxiety was updated.

Other Meds:

Current Illness:

ID: 1643712
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Laryngitis; This spontaneous case was reported by a consumer and describes the occurrence of LARYNGITIS (Laryngitis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LARYNGITIS (Laryngitis). At the time of the report, LARYNGITIS (Laryngitis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. Treatment medications were unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643713
Sex: F
Age: 36
State: NY

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: lupus anticoagulant; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptom List: Unevaluable event

Symptoms: Pressure in back; spider vein; capillaries that burst; red arm; petechiae outburst; muscle twitch; Stiff neck; Hearing issue; missed second dose; Head numbness; covid arm; brain fog; fatigue; swollen lymph; joint pain on left knee,; arm pain/Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries that burst), ERYTHEMA (red arm) and PETECHIAE (petechiae outburst) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), PRODUCT DOSE OMISSION ISSUE (missed second dose), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache). The patient was treated with DOXYCYCLINE for Petechiae, at an unspecified dose and frequency; METHYLPREDNISOLONE for Swollen lymph nodes, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure in back), SPIDER VEIN (spider vein), CAPILLARY FRAGILITY (capillaries that burst), ERYTHEMA (red arm), PETECHIAE (petechiae outburst), MUSCLE TWITCHING (muscle twitch), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEARING DISABILITY (Hearing issue), HYPOAESTHESIA (Head numbness), VACCINATION COMPLICATION (covid arm), FEELING ABNORMAL (brain fog), FATIGUE (fatigue), LYMPHADENOPATHY (swollen lymph), ARTHRALGIA (joint pain on left knee,), MYALGIA (arm pain/Muscle pain) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antiphospholipid antibodies: positive (Positive) Positive. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Pep scan came normal. No concomitant medications were reported by the reporter. Treatment mediations includes Advil and 2 compression devices were used.

Other Meds:

Current Illness:

ID: 1643714
Sex: U
Age:
State:

Vax Date: 06/25/2021
Onset Date: 06/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 25, 2021, patient experienced a device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out). At the time of the report, device connection issue (small amount leaked out of the injection site), off-label use (needed an additional shot in the same sitting) and incorrect dose administered (possible over dose/some of the first leaked out) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable. No concomitant medication or treatment information reported.

Other Meds:

Current Illness:

ID: 1643715
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: face is swollen; Rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face is swollen) and RASH (Rash all over body) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (face is swollen) and RASH (Rash all over body). At the time of the report, SWELLING FACE (face is swollen) and RASH (Rash all over body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment was reported. No concomitant medication was reported

Other Meds:

Current Illness:

ID: 1643716
Sex: F
Age:
State: HI

Vax Date: 06/27/2021
Onset Date: 06/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: site is red; really swollen; muscle pain/ I am in excruciating pain from this shot; I couldn't sleep last night; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (I couldn't sleep last night), VACCINATION SITE ERYTHEMA (site is red), VACCINATION SITE SWELLING (really swollen) and MYALGIA (muscle pain/ I am in excruciating pain from this shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Jun-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jun-2021, the patient experienced INSOMNIA (I couldn't sleep last night) and MYALGIA (muscle pain/ I am in excruciating pain from this shot). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (site is red) and VACCINATION SITE SWELLING (really swollen). At the time of the report, INSOMNIA (I couldn't sleep last night), VACCINATION SITE ERYTHEMA (site is red), VACCINATION SITE SWELLING (really swollen) and MYALGIA (muscle pain/ I am in excruciating pain from this shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant Concomitant medications were reported. No Treatment information Provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643717
Sex: F
Age: 70
State: WA

Vax Date: 04/24/2021
Onset Date: 06/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Infected at the injection; Nauseous; Thrown up; Bruises where the lump was; Spots all over where the lump was; Hard, not hot, knot; Red in a circle around where it swelled up; Swelled up, swelling started to go down; Hurt a little bit, but was nothing bad; 1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 002C12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad). On 25-Jun-2021, the patient experienced INDURATION (Hard, not hot, knot). On 26-Jun-2021, the patient experienced CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), NAUSEA (Nauseous) and VOMITING (Thrown up). On an unknown date, the patient experienced VACCINATION SITE INFECTION (Infected at the injection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down), PAIN (Hurt a little bit, but was nothing bad), CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), VACCINATION SITE INFECTION (Infected at the injection), NAUSEA (Nauseous) and VOMITING (Thrown up) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant product use was provided by the reporter. Treatment medication included She had been using ice on the area and taking an antihistamine.

Other Meds:

Current Illness:

ID: 1643718
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: confused; drained of energy; I can't recall info that I should know; can't do two things at once; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once). At the time of the report, CONFUSIONAL STATE (confused), ASTHENIA (drained of energy), MEMORY IMPAIRMENT (I can't recall info that I should know) and DISTURBANCE IN ATTENTION (can't do two things at once) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1643719
Sex: M
Age: 57
State: VA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Lethargic; Chills; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm). At the time of the report, LETHARGY (Lethargic), CHILLS (Chills) and MYALGIA (Sore Arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2021-239018 (Patient Link).

Other Meds: BIKTARVY

Current Illness:

ID: 1643720
Sex: F
Age:
State: PA

Vax Date: 06/24/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: sleeping all day; sweating; redness; Vomiting; Nausea; her arm started getting sore / body aches.; swelling of lymph node; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired). At the time of the report, SOMNOLENCE (sleeping all day), HYPERHIDROSIS (sweating), ERYTHEMA (redness), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (her arm started getting sore / body aches.), LYMPHADENOPATHY (swelling of lymph node) and FATIGUE (extremely tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. Patient states that 6 hours later, arm started getting sore, redness, extremely tired, and the next day she slept all day. Patient also experienced body aches, swelling of the lymph node underneath the same arm of the injection, some nausea and vomiting and sweating. HCP told her should have received something like Tylenol or Ibuprofen for the pain, aches, soreness, and nausea and vomiting. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1643721
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. No concomitant medications were mentioned. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1643722
Sex: U
Age:
State:

Vax Date: 06/24/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: still not feel normal; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (still not feel normal) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (still not feel normal). At the time of the report, FEELING ABNORMAL (still not feel normal) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment details were reported. Patient reported that it has been 4 days since the first shot and still feeling abnormal.

Other Meds:

Current Illness:

ID: 1643723
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: disrupt your periods, missed my last 2 periods; had a lot a couple weird side affects; certain foods and drinks taste like chemicals or smell like s; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s). At the time of the report, MENSTRUATION IRREGULAR (disrupt your periods, missed my last 2 periods), VACCINATION COMPLICATION (had a lot a couple weird side affects) and DYSGEUSIA (certain foods and drinks taste like chemicals or smell like s) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1643724
Sex: F
Age: 70
State: CT

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: sore injection site arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore injection site arm). On 05-Feb-2021, VACCINATION SITE PAIN (sore injection site arm) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter This case was linked to MOD-2021-238979 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Non-significant follow up appended - Email address updated.

Other Meds:

Current Illness:

ID: 1643725
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: long term stomach sensitivity /; Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jun-2021 and was forwarded to Moderna on 28-Jun-2021. This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea). At the time of the report, ABDOMINAL DISCOMFORT (long term stomach sensitivity /) and DIARRHOEA (Diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication use was unknown Treatment information was unknown

Other Meds:

Current Illness:

ID: 1643726
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of bronchitis (diagnosed last week) and bronchial asthma in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced bronchitis (diagnosed last week) and bronchial asthma. At the time of the report, bronchitis (diagnosed last week) and bronchial asthma outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication details reported. Treatment included 2 antibiotics and steroids.

Other Meds:

Current Illness:

ID: 1643727
Sex: U
Age:
State:

Vax Date: 06/24/2021
Onset Date: 06/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Arm that got the shot has been feeling sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ( Arm that got the shot has been feeling sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jun-2021, the patient experienced VACCINATION SITE PAIN ( Arm that got the shot has been feeling sore). At the time of the report, VACCINATION SITE PAIN ( Arm that got the shot has been feeling sore) outcome was unknown. No concomitant medications was reported by the reporter No treatment medications was provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1643728
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Tingling through my whole body; Numbness through my whole body; It affected my sleep; It affected my work; it affected my daily activities; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling through my whole body), HYPOAESTHESIA (Numbness through my whole body), INSOMNIA (It affected my sleep), IMPAIRED WORK ABILITY (It affected my work) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it affected my daily activities) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling through my whole body), HYPOAESTHESIA (Numbness through my whole body), INSOMNIA (It affected my sleep), IMPAIRED WORK ABILITY (It affected my work) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it affected my daily activities). At the time of the report, PARAESTHESIA (Tingling through my whole body), HYPOAESTHESIA (Numbness through my whole body), INSOMNIA (It affected my sleep), IMPAIRED WORK ABILITY (It affected my work) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it affected my daily activities) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No Treatment medications were reported.

Other Meds:

Current Illness:

ID: 1643729
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Missed 2nd dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1643730
Sex: F
Age: 86
State: MO

Vax Date: 05/10/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. No Medical History information was reported. On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28Jun2021). On 10-May-2021, PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were provided.

Other Meds:

Current Illness:

ID: 1643731
Sex: F
Age: 27
State: TX

Vax Date: 06/27/2021
Onset Date: 06/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210628; Test Name: Body temperature; Result Unstructured Data: 38.4?C; Test Date: 20210628; Test Name: Body temperature; Result Unstructured Data: 37.4?C; Test Date: 20210628; Test Name: Body temperature; Result Unstructured Data: 37?C

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: She was uncomfortable in bed because of this; Delay of 3 days in her period; Next period suffer a change in flow (lower than usual); Fever of 38.4?C; Strong pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (She was uncomfortable in bed because of this), MENSTRUATION DELAYED (Delay of 3 days in her period), PAIN IN EXTREMITY (Strong pain in her arm), MENSTRUAL DISORDER (Next period suffer a change in flow (lower than usual)) and PYREXIA (Fever of 38.4?C) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jun-2021, the patient experienced PAIN IN EXTREMITY (Strong pain in her arm). On 28-Jun-2021, the patient experienced PYREXIA (Fever of 38.4?C). On an unknown date, the patient experienced DISCOMFORT (She was uncomfortable in bed because of this), MENSTRUATION DELAYED (Delay of 3 days in her period) and MENSTRUAL DISORDER (Next period suffer a change in flow (lower than usual)). The patient was treated with IBUPROFEN ongoing since an unknown date for Fever, at an unspecified dose and frequency. On 28-Jun-2021, PYREXIA (Fever of 38.4?C) had resolved. At the time of the report, DISCOMFORT (She was uncomfortable in bed because of this), MENSTRUATION DELAYED (Delay of 3 days in her period), PAIN IN EXTREMITY (Strong pain in her arm) and MENSTRUAL DISORDER (Next period suffer a change in flow (lower than usual)) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jun-2021, Body temperature: 38.4 (High) 38.4?C, 37.4?c (High) 37.4?C and 37?c (normal) 37?C. Concomitant medication included birth control pills. Patient reported that all symptoms faded in a couple of days as normal identified side effects. This case was linked to MOD-2021-187591 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Outcome of event was updated to resolved and event of menstrual disorder added. lab data updated from initial source.

Other Meds:

Current Illness:

ID: 1643732
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Consumer answered "Yes" when asked if they had received the Moderna COVID-19 and experienced a side effect; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Consumer answered "Yes" when asked if they had received the Moderna COVID-19 and experienced a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (Consumer answered "Yes" when asked if they had received the Moderna COVID-19 and experienced a side effect). At the time of the report, UNEVALUABLE EVENT (Consumer answered "Yes" when if they had received the Moderna COVID-19 and experienced a side effect) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1643733
Sex: M
Age: 57
State: VA

Vax Date: 03/23/2021
Onset Date: 04/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Brain fog; Swelling of Lips; Headache; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), FEELING ABNORMAL (Brain fog), LIP SWELLING (Swelling of Lips) and HEADACHE (Headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore Arm). On 28-Jun-2021, the patient experienced FEELING ABNORMAL (Brain fog), LIP SWELLING (Swelling of Lips) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore Arm), FEELING ABNORMAL (Brain fog), LIP SWELLING (Swelling of Lips) and HEADACHE (Headache) outcome was unknown. This case was linked to MOD-2021-238986 (Patient Link).

Other Meds: BIKTARVY

Current Illness:

ID: 1643734
Sex: U
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Received the first dose on March 24, 2021, are they still eligible for the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the first dose on March 24, 2021, are they still eligible for the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the first dose on March 24, 2021, are they still eligible for the second dose). On 24-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Received the first dose on March 24, 2021, are they still eligible for the second dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1643735
Sex: M
Age: 28
State: CA

Vax Date: 06/21/2021
Onset Date: 06/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Patient received his first dose of the Moderna Covid-19 vaccine as an expired vaccine.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received his first dose of the Moderna Covid-19 vaccine as an expired vaccine.) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received his first dose of the Moderna Covid-19 vaccine as an expired vaccine.). On 21-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient received his first dose of the Moderna Covid-19 vaccine as an expired vaccine.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information were provided. No treatment information was provided. The vaccine was placed in the refrigerator on 20-May-2021. The vaccine expiration date was 19-Jun-2021. No Other Adverse Events were reported.

Other Meds:

Current Illness:

ID: 1643736
Sex: F
Age:
State: NC

Vax Date: 06/11/2021
Onset Date: 06/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2021-239102, MOD-2021-239102.

Other Meds:

Current Illness:

ID: 1643737
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: first dose of the vaccine two months ago and missed my second dose appointment; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose of the vaccine two months ago and missed my second dose appointment) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose of the vaccine two months ago and missed my second dose appointment). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose of the vaccine two months ago and missed my second dose appointment) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.

Other Meds:

Current Illness:

ID: 1643738
Sex: M
Age: 79
State: TX

Vax Date: 06/26/2021
Onset Date: 06/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: congestion; Soreness at the injection site on left arm; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion) and VACCINATION SITE PAIN (Soreness at the injection site on left arm) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C0A) for COVID-19 vaccination. The patient's past medical history included Surgery (artificial heart valve) and Dental surgery NOS (received amoxicillin on 23JUNE2021 prior to vaccine). Concomitant products included AMOXICILLIN for an unknown indication. On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jun-2021, the patient experienced NASAL CONGESTION (congestion) and VACCINATION SITE PAIN (Soreness at the injection site on left arm). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date for Rhinitis, at an unspecified dose and frequency. On 28-Jun-2021, VACCINATION SITE PAIN (Soreness at the injection site on left arm) had resolved. At the time of the report, NASAL CONGESTION (congestion) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient received amoxicillin on 23-JUN-2021 prior to vaccine for a dental procedure and consumed Mucinex 3 weeks ago for cold symptoms, which was unrelated to vaccine injection as symptoms appeared prior to injection. It was reported that the patient got the second shot and was fine. Treatment details were not provided. Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up information received on 26-Jul-2021, and received 2nd dose details, updated outcome of nasal congestion to resolved.

Other Meds: AMOXICILLIN

Current Illness:

ID: 1643739
Sex: M
Age: 16
State: TX

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: 16 year old son got the Moderna Covid-19 Vaccine accidentally; sore arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old son got the Moderna Covid-19 Vaccine accidentally) and MYALGIA (sore arm) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. No Medical History information was reported. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old son got the Moderna Covid-19 Vaccine accidentally). On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old son got the Moderna Covid-19 Vaccine accidentally) and MYALGIA (sore arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication not provided. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1643740
Sex: F
Age:
State: IN

Vax Date: 01/30/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210628; Test Name: Blood Test; Result Unstructured Data: Red Blood cells not normal; Test Date: 20210628; Test Name: Chest X-Ray; Result Unstructured Data: Normal; Test Date: 20210628; Test Name: Electrocardiogram; Result Unstructured Data: Normal

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: anemia; Red blood cell not normal; Shortness of breath; Chest pain; cough; severe heart burn; Light headed; headache; weakness; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (anemia), ASTHENIA (weakness), DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain) and COUGH (cough) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy, Allergy to antibiotic, Allergy to antibiotic, Drug allergy, Drug allergy, Asthma (Shortness of Breath) since 1969, Acid reflux (esophageal) (Severe Heartburn) since 1970 and Anxiety (Severe Heartburn) since 2000. Concomitant products included OMEPRAZOLE from 1970 to an unknown date for Acid reflux (esophageal), SERTRALINE from 2000 to an unknown date for Anxiety, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) from 1996 to an unknown date for Asthma, ROSUVASTATIN from 2019 to an unknown date for Cholesterol, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) from 2005 to an unknown date, CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D3) from 2000 to an unknown date, VITAMINS NOS from 2018 to an unknown date and PROBIOTICS NOS from 2020 to an unknown date for an unknown indication. On 30-Jan-2021 at 3:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021 at 3:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. In May 2021, the patient experienced ASTHENIA (weakness), COUGH (cough), DYSPEPSIA (severe heart burn), DIZZINESS (Light headed) and HEADACHE (headache). On 21-Jun-2021, the patient experienced DYSPNOEA (Shortness of breath) and CHEST PAIN (Chest pain). On 28-Jun-2021, the patient experienced RED BLOOD CELL ABNORMALITY (Red blood cell not normal). On an unknown date, the patient experienced ANAEMIA (anemia). The patient was treated with PREDNISONE on 01-Jul-2021 for Autoimmune haemolytic anaemia, at a dose of 30 mg, 60 mg, 120 mg. At the time of the report, ANAEMIA (anemia) outcome was unknown, ASTHENIA (weakness), DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), COUGH (cough), RED BLOOD CELL ABNORMALITY (Red blood cell not normal), DIZZINESS (Light headed) and HEADACHE (headache) had not resolved and DYSPEPSIA (severe heart burn) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jun-2021, Blood test: abnormal (abnormal) Red Blood cells not normal. On 28-Jun-2021, Chest X-ray: normal (normal) Normal. On 28-Jun-2021, Electrocardiogram: normal (normal) Normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Lab Data - Patient had done Blood test on 02 Jul 2021, 09 Jul 2021 and 19 Jul 2021 Concomitant medications taken were Newchapter and Fortify Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: follow up information received contains patient details, medical history, lab data, added events - Dyspnoea, Asthenia, Dizziness, Headache, Dyspepsia, Cough, Chest Pain, concomitant medications, treatment medications.

Other Meds: ADVAIR; SERTRALINE; OMEPRAZOLE; ROSUVASTATIN; ASPIRIN (E.C.); CITRACAL + D3; VITAMINS NOS; PROBIOTICS NOS

Current Illness: Acid reflux (esophageal) (Severe Heartburn); Allergy to antibiotic; Anxiety (Severe Heartburn); Asthma (Shortness of Breath); Drug allergy

ID: 1643741
Sex: F
Age: 58
State: GA

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: mildly painful in my arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (mildly painful in my arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B1321A and 011D21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included VITAMIN B COMPLEX (B-COMPLEX [VITAMIN B COMPLEX]), VITAMIN D [VITAMIN D NOS], VITAMIN A [RETINOL], PROBIOTICS NOS and OMEGA-3 NOS for an unknown indication. On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 16-May-2021, the patient experienced MYALGIA (mildly painful in my arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (mildly painful in my arm) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-239035 (Patient Link).

Other Meds: B-COMPLEX [VITAMIN B COMPLEX]; VITAMIN D [VITAMIN D NOS]; VITAMIN A [RETINOL]; PROBIOTICS NOS; OMEGA-3 NOS

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am